NFKB1 and COVID-19: Zhang et al. used a network pharmacology analysis technique followed by experimental validation and reported that sophocarpine may have potential therapeutic effects on coronavirus disease 2019 (COVID-19) by mediating cytokine release and the nuclear factor NF-κB signaling pathway (Zhang and Zhang, 2022).